LINDSEY MINSHEW: Open Payments
NPI 1386408433 · LIVE OAK, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$212 in 13 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $491 · 2025 $212
Food & beverage: $212
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $57 |
| GlaxoSmithKline, LLC. | 3 | $43 |
| ABBVIE INC. | 2 | $38 |
| Novo Nordisk Inc | 1 | $16 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| Dexcom, Inc. | 1 | $15 |
| Exact Sciences Corporation | 1 | $15 |
| Axsome Therapeutics, Inc. | 1 | $12 |
Products named: TRELEGY ELLIPTA, MOUNJARO, VRAYLAR, Ozempic, JARDIANCE, CAPLYTA, Dexcom G6 Transmitter, The Cologuard Plus Collection Kit.
Industry payments across FL — which companies pay providers there.
